● A weekly research bulletin · est. 2026

The evidence behind what works.

We read the whole sports medicine, rehab & performance literature every week, critically appraise the papers that matter — and tell you what to do about them.

★★★★★ Built for physiotherapists, sports doctors & S&C coaches.

Endurance athletes competing
appraised · not summarised
0
papers screened / week
0
selected for the issue
0
landmark paper paired
001
current issue
01

Summaries are everywhere. Judgement is rare.

the method

Most feeds tell you what a paper said. We tell you whether it’s any good, how big the effect really is, and whether it should change what you do on Monday.

1 FIND

Every journal, every week

We harvest new and landmark research across sports medicine, rehab & performance — the whole literature, not a hand-picked handful — ranked by citation and field-weighted impact.

2 APPRAISE

Critically, not credulously

Each paper gets the same rigorous read: risk of bias, effect size vs. clinical significance, the gap it doesn’t fill, and the landmark study it builds on or contradicts.

3 SIGN-OFF

A clinician approves every word

Nothing ships on autopilot. A named clinical editor reviews and signs off every issue before it reaches you. Rigour is the product.

Clinician assessing an athlete

● signal ÷ noise

We read 200+ papers so you read 5.

The ones that matter — plus the one that’s overhyped — appraised for what they actually change in the clinic and on the field.

02

The lead

this week’s issue

One paper, appraised. The same seven-field record every week — learn the shape once, read fast forever.

loading this week’s lead…
03

The five

the rest of what mattered

Free readers get the verdict line. Clinician members get the full appraisal on every paper — plus the searchable archive.

04

Free forever, or go deeper.

access

The weekly signal is free for good. Premium unlocks the full appraisal on every paper, the landmark deep-dives, and the searchable archive — for less than a coffee a month.

Free
£0 forever

The weekly signal — genuinely useful on its own.

Subscribe free
  • The weekly email digest
  • The Lead paper — full appraisal
  • Verdict & quality score on all of The Five
  • The weekly Overhyped pick
  • Tailored to your interests
  • Full appraisal on The Five
  • Landmark deep-dives & archive
Most popular
Premium
£45 /year

Just £3.75/mo, billed annually — 25% off monthly.

Start 7-day free trial
  • Everything in Free, plus:
  • Full appraisal on all five — methods, effect size, the gap
  • Latest + Landmark deep dives
  • The complete searchable archive
  • CPD-loggable export
  • Cancel anytime

Clinics, universities & teams — multi-seat access on one invoice. Get in touch →

05

Standards

a human signs off
“Statistically significant isn’t the same as significant. Our whole job is telling you the difference — and whether it changes anything.”

— The Dose-Response clinical editor

Appraisal, not summary
Risk of bias, effect size, generalisability — the judgement layer everyone else skips.
Latest + Landmark
Every new paper placed against the foundational study it builds on or overturns.
A human owns the verdict
AI reads at scale. A named clinician signs off. Nothing ships unreviewed.
Clinician treating a patient